On Friday we received the news that Spinraza - the latest (and first) treatment for spinal muscular atrophy - had been approved by the EMA for use in all types of SMA across Europe. Here's our catch up chat on the subject, and you can read the full EMA report here: https://www.muscleowl.com/single-post/2017/04/21/SPINRAZA-APPROVED-EMA